Related Experiment Video

Updated: Aug 19, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions

T A Tran1, J S Ross, J A Carlson

  • 1Department of Pathology and Laboratory Medicine, Albany Medical College and Samuel S. Stratton Veterans Administration Medical Center, NY 12208, USA.

Human Pathology
|October 22, 1998
PubMed

Insights

Malignant melanoma (MM) shows higher expression of cell-cycle proteins like cyclin A and p34cdc2 compared to benign nevi. Overexpression of these proteins correlates with poorer patient survival in melanoma.

Area of Science:

  • Oncology
  • Cell Biology
  • Dermatopathology

Background:

  • Cyclins and cyclin-dependent kinases are implicated in cancer development.
  • Understanding their role in melanoma progression is crucial.

Purpose of the Study:

  • To investigate the expression of cyclin A, cyclin B, and p34cdc2 in benign and malignant melanocytic lesions.
  • To correlate protein expression with melanoma characteristics and patient outcomes.

Main Methods:

  • Immunohistochemical analysis of formalin-fixed, paraffin-embedded tissues from 66 malignant melanomas and 60 benign nevi.
  • Comparison of cyclin and p34cdc2 expression with Ki-67 and mitotic index.
  • Correlation of protein expression with histological type, tumor thickness, Clark's level, and survival.

Main Results:

  • Malignant melanoma exhibited significantly higher immunoreactivity for cyclin A, cyclin B, p34cdc2, and Ki-67 than benign nevi.
  • Cyclin A, p34cdc2, and Ki-67 showed strong co-expression in malignant melanoma.
  • Overexpression of cyclin A and p34cdc2 correlated with adverse prognostic factors and decreased survival in invasive melanoma.

Conclusions:

  • Mitotic cyclins and cyclin-dependent kinases play potential roles in the pathogenesis and progression of malignant melanoma.
  • Cyclin A and Ki-67 expression are associated with reduced patient survival in invasive melanoma.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...